The goal of the Iliev Laboratory is to define the molecular mechanisms by which fungal and bacterial symbionts, and their interaction with the host influence host immunity, cancer, neuroimmune processes, and inflammation.To better understand the role of mycobiota, Dr. Iliev and his colleagues have developed in vivo models, model fungal strains and bioinformatics pipelines that aid with tools to study the role of gut fungi in mucosal immunity during health and during conditions, such as inflammatory bowel disease, allergy and immunosuppression, in which fungi can contribute to pathologies. We welcome collaboration with other labs and investigators that seek to better understand gut microbiota and mycobiota.